Misappropriation and Unverified Handling of Resident Narcotic Medications
Summary
The deficiency involves the facility’s failure to protect residents from misappropriation of narcotic medications, resulting in discrepancies between narcotic sign-out records and actual administration for multiple residents. For one resident with diagnoses including gangrene, PVD, cellulitis, type 2 diabetes, and muscle weakness, the care plan identified actual pain related to cellulitis and directed staff to monitor and document pain and side effects of pain medications. The resident had an order for oxycodone-acetaminophen 10-325 mg every six hours as needed. The MAR for this resident in March showed only one dose administered on a specific date, while the narcotic sign-out sheet showed that an LPN signed out two doses of the same medication at the same time, creating an unexplained extra dose that was not documented as given to the resident. For a second resident with COPD, CKD stage 3, hepatitis C, hypothyroidism, morbid obesity, mood disorder, bipolar disease, and anxiety, the MDS showed intact cognition and partial to moderate assistance with ADLs. This resident had a physician’s order for hydrocodone-acetaminophen 10-325 mg: one tablet every morning and at bedtime for moderate to severe pain, and one tablet every 12 hours as needed for breakthrough pain. Review of narcotic sign-out sheets over several months revealed that the same LPN repeatedly signed out additional doses of hydrocodone-acetaminophen at intervals of less than six hours, and in some instances signed out two tablets at once, which did not follow the physician’s orders. A confidential interview reported that when this LPN worked, she would sign out extra doses of this resident’s hydrocodone-acetaminophen, sometimes multiple doses at the same time and date, even though the resident was only to receive one pill at a time every 12 hours and did not request additional doses. The resident, who was alert and oriented, confirmed receiving pain medication every 12 hours, stated it controlled her pain, and reported that she did not ask for or receive extra doses, but became aware that extra doses were being signed out and discussed this with the Ombudsman. For a third resident with PVD, COPD, CKD, heart failure, type 2 diabetes, hypertension, gout, and cerebrovascular disease, the discharge MDS showed intact cognition and independence with ADLs. This resident had an order for oxycodone-acetaminophen 5-325 mg every six hours as needed for moderate to severe pain and was discharged from the facility on a specified date in November. The narcotic sign-off sheet showed that after the resident’s discharge, one LPN signed out a dose of the medication two days later, and the same LPN involved in the other discrepancies signed out two additional doses the following day and one more dose the day after that. The narcotic sheet indicated these medications were wasted and documented that the two LPNs witnessed each other’s wastage, but during the survey the facility administration was unable to verify that the medications were actually wasted. The DON acknowledged the findings on the narcotic sign-off sheet and stated she had no explanation for why narcotics were being pulled for this resident days after discharge. Facility policies on controlled substance administration and resident rights stated that safeguards were to be in place to prevent loss or diversion of controlled substances and that residents had the right to be free from misappropriation of their property, but the events described show that these safeguards were not effectively implemented for the residents involved. Additionally, confidential interviews indicated that concerns about the LPN’s handling of narcotics for at least one resident had been raised to the DON multiple times since November, specifically that extra doses were being signed out in a manner not consistent with physician orders. The DON later confirmed that when this LPN worked, there were consistently additional doses of hydrocodone-acetaminophen signed out for the resident in question and verified the surveyors’ findings on the narcotic sign-off sheets. Another LPN who had co-signed wastage entries for a discharged resident’s narcotics was later found to have been working with a suspended nursing license due to narcotic diversion. These documented patterns of signing out extra doses, signing out narcotics after a resident’s discharge, and the inability to verify wastage demonstrate that the facility did not ensure residents were free from misappropriation of narcotic medications, contrary to its own policies and resident rights. The facility’s written policies on controlled substances and resident rights emphasized promoting safe, high-quality care, maintaining safeguards to prevent loss or diversion of controlled substances, and ensuring residents’ freedom from misappropriation of property. The policy on abuse, neglect, and exploitation stated that the facility would not employ individuals with disciplinary action against their professional license. Despite these policies, the documented narcotic sign-out patterns, the lack of correlation with MAR entries and resident reports, the signing out of narcotics for a resident no longer in the facility, and the employment of an LPN whose license was suspended for narcotic diversion all contributed to the deficiency related to misappropriation of residents’ narcotic medications.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release June 24, 2026) and official state health department websites — never guesswork.
Trusted by long-term care providers and associations.



